NCT02436499View on ClinicalTrials.gov

Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes.

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Chronic Migraine
Interventions
DRUG

Botulinum Toxin-A

Trial Locations (1)

R3E0T5

University of Manitoba, Winnipeg

All Listed Sponsors
collaborator

Dr. Behzad Mansouri (Co-Primary Investigator)

UNKNOWN

lead

University of Manitoba

OTHER

NCT02436499 - Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes. | Biotech Hunter | Biotech Hunter